Generally speaking, the above evidence suggests that the p14ARF/MDM2/TP53 pathway is a vital regulator in tumor development and progression, indicating the biological plausibility of the relevance of the p14ARF/MDM2/TP53 pathway to the prognosis of ESCC, as shown by our research. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.